Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Tolerability of PRO-185 in Healthy Volunteers
NCT05470868Phase 1Completed
- Sponsor
- Laboratorios Sophia
- Start
- Feb 2023
- Primary completion
- May 2023
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of naphazoline and GenTeal Gel in Conjunctival hyperemia, sponsored by Laboratorios Sophia. Primary endpoints: Intraocular Pressure Increment at Day 10, Heart Rate Increment at Day 10 and 4 more. Started Feb 2023; status: completed.
02
Drugs
naphazolineGenTeal Gel
03
Conditions
Conjunctival hyperemia
Beyond the preview
Go deeper on NCT05470868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05470868.